Defence Therapeutics’ breakthrough in cancer treatment: AccuTOX® shows promise against lung tumours
Health Europa » Pharma News
by
5d ago
Defence Therapeutics has announced the successful testing of a new formulation of its ACCUM-002TM Dimer CDCA-SV40 against lung tumours ..read more
Visit website
Defence Therapeutics granted FDA approval for Phase I Clinical Trial of AccuTOX®
Health Europa » Pharma News
by
3w ago
Defence Therapeutics has announced a pivotal milestone: the U.S. Food and Drug Administration (FDA) has granted a green light with a "Study May Proceed ..read more
Visit website
Defence Therapeutics applies to use AccuTOX® as an advanced tumour treatment
Health Europa » Pharma News
by
1M ago
Defence Therapeutics has submitted an Investigational New Drug application for AccuTOX®, an injectable anticancer molecule ..read more
Visit website
RECOVERY trial set to investigate revolutionary new flu treatments
Health Europa » Pharma News
by
2M ago
The groundbreaking RECOVERY trial, celebrated for its discovery of four effective treatments for COVID-19, is broadening its horizons by venturing into the realm of ..read more
Visit website
AccuTOX® anticancer drug demonstrates exciting antigen cross-presentation
Health Europa » Pharma News
by
3M ago
Defence Therapeutics Inc., a prominent Canadian biopharmaceutical company renowned for its work in immune-oncology vaccines and drug delivery technologies, has announced the discovery of ..read more
Visit website
Administration of AccuTOX™-chitosan inhibits the growth of established solid lymphoma in animals
Health Europa » Pharma News
by
3M ago
Defence Therapeutics has announced that systemic administration of novel AccuTOX™-chitosan encapsulated formulation inhibits the growth of pre-established solid lymphoma resulting in their progressive shrinking ..read more
Visit website
Defence Therapeutics Inc. releases Accum® study revealing its anti-cancer properties
Health Europa » Pharma News
by
3M ago
Defence Therapeutics Inc. have announced the publication of a peer-reviewed study on the anti-cancer properties of its unconjugated Accum ..read more
Visit website
Accum®-mRNA lipid nanoparticles have double the antibody response of traditional mRNA vaccines
Health Europa » Pharma News
by
4M ago
Defence Therapeutics has announced a groundbreaking achievement, demonstrating that its Accum®-mRNA lipid nanoparticles elicit twice the antibody response of mRNA-based vaccines. The company's encapsulation strategy ..read more
Visit website
The critical vaccine cold chain
Health Europa » Pharma News
by
4M ago
Dr Nenad Miljković from the European Association of Hospital Pharmacists (EAHP) outlines the critical role of cold chain storage in maintaining the efficacy and ..read more
Visit website
Developing mRNA vaccine technology
Health Europa » Pharma News
by
4M ago
Following the unprecedented development of vaccines during the COVID-19 pandemic, we spoke to Dinah Knotts about mRNA vaccine technology and what further opportunities it ..read more
Visit website

Follow Health Europa » Pharma News on FeedSpot

Continue with Google
Continue with Apple
OR